Stock Market & Financial Investment News

News Breaks September 12, 2012 06:41 EDT AMGN Amgen downgraded to Neutral from Outperform at RW Baird Baird downgraded Amgen citing valuation. Price target raised to $84 from $83. News For AMGN From The Last 14 Days Check below for free stories on AMGN the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 13, 2013 08:55 EDT AMGN Biosimiliar drug bill to be taken up in Senate, LA Times reports Subscribe for More Information May 9, 2013 16:48 EDT AMGN Amgen, Zhejiang Beta Pharma announce joint venture in China Subscribe for More Information May 7, 2013 16:31 EDT AMGN Amgen announces Phase 3 head-to-head study of Vectibix versus Erbitux Subscribe for More Information May 6, 2013 07:01 EDT AMGN Transgenomic, Amgen sign collaboration agreement for CE-IVD CRC RAScan tests Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.